Challenges and future expectations of reversed gene therapy

Journal of Nanoscience and Nanotechnology

Volumn 11, Issue 10, 2011, Pages 8634-8638

  He, Nongyue ^a   Zeng, Xin ^a   Wang, Weida ^b,c   Deng, Kunlong ^b   Pan, Yunzhi ^b   Xiao, Li ^b   Zhang, Jia ^b   Li, Kai ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c Suzhou Institute of Chinese Materia Medica   (China)

Author keywords

CCR5; Hematopoietic Stem Cells; HIV; Loss of Function; Reversed Gene Therapy

Indexed keywords

CCR5; CELLULAR MOLECULES; FUNCTIONAL GENES; HEMATOPOIETIC STEM CELLS; HIV; MUTATED GENES; PATHOGEN INFECTION; REGULATORY SYSTEMS;

GENETIC ENGINEERING; STEM CELLS;

GENE THERAPY;

CHEMOKINE RECEPTOR CCR5;

ARTICLE; FORECASTING; GENE SILENCING; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN; METHODOLOGY; MUTATION; PHYSIOLOGY; STEM CELL;

FORECASTING; GENE SILENCING; GENE TARGETING; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MUTATION; RECEPTORS, CCR5; STEM CELLS;

EID: 84857160413     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2011.5723     Document Type: Conference Paper

References (46)

1. L. L. Chen, J. Zhang, H. L. Gao, D. F. Liao, and K. Li, J. University of South China (Medical Edition) 33, 166 (2005).
2. K. Allers, G. Hutter, J. Hofmann, C. Loddenkemper, K. Rieger, and E. Thiel, and T. Schneider, Blood 117, 279 (2011).
3. R. J. Landovitz and J. S. Currier, N. Engl. J. Med. 361, 1768 (2009).
4. A. Lombardo, P. Genovese, C. M. Beausejour, S. Colleoni, Y. L. Lee, K. A. Kim, D. Ando, F. D. Urnov, C. Galli, P. D. Gregory, M. C. Holmes, and L. Naldini, Nat. Biotechnol. 25, 1298 (2007).
5. T. Li, S. Huang, W. Z. Jiang, D. Wright, M. H. Spalding, D. P. Weeks, and B. Yang, Nucleic. Acids Res. 39, 359 (2011).
6. E. E. Perez, J. Wang, J. C. Miller, Y. Jouvenot, K. A. Kim, O. Liu, N. Wang, G. Lee, V. V. Bartsevich, Y. L. Lee, D. Y. Guschin, I. Rupniewski, A. J. Waite, C. Carpenito, R. G. Carroll, J. S. Orange, F. D. Urnov, E. J. Rebar, D. Ando, P. D. Gregory, J. L. Riley, M. C. Holmes, and C. H. June, Nat. Biotechnol. 26, 808 (2008).
7. I. Vural, C. Sarisozen, and S. S. Olmez, J. Biomed. Nanotechnol. 7, 426 (2011).
8. W. Wijagkanalan, S. Kawakami, Y. Higuchi, F. Yamashita, and M. Hashida, J. Control. Release 149, 42 (2011).
9. S. Herber-Jonat, R. Mittal, S. Gsinn, H. Bohnenkamp, E. Guenzi, and A. Schulze, Inflamm. Res. 60, 245 (2011).
10. S. G. Kitchen and J. A. Zack, Curr. Opin. HIV. AIDS 6, 68 (2011).
11. J. N. Warnock, C. Daigre, and M. Al-Rubeai, Methods Mol. Biol. 737, 1 (2011).
12. R. Singh and H. S. Nalwa, J. Biomed. Nanotechnol. 7, 489 (2011).
13. F. E. Alemdaroglu and A. Herrmann, Org. Biomol. Chem. 5, 1311 (2007).
14. S. C. De Smedt, J. Demeester, and W. E. Hennink, Pharm. Res. 17, 113 (2000)
15. D. Fischer, T. Bieber, Y. Li, H. P. Elsasser, and T. Kissel, Pharm. Res. 16, 1273 (1999).
16. R. Goyal, S. K. Tripathi, S. Tyagi, A. Sharma, P. Kumar, K. R. Ram, D. K. Chowdhuri, Y. Shukla, and K. C. Gupta, J. Biomed. Nanotechnol. 7, 52 (2011).
17. K. Ma, M. X. Hu, Y Qi, J. H. Zou, L. Y Qiu, Y Jin, X. Y Ying, and H. Y Sun, Biomaterials 30, 6109 (2009).
18. Z. Q. Feng, X. Chu, N. P. Huang, T. Wang, Y Wang, X. Shi, Y Ding, and Z. Z. Gu, Biomaterials 30, 2753 (2009).
19. H. Oliveira, L. R. Pires, R. Fernandez, M. C. Martins, S. Simoes, and A. P. Pego, J. Biomed. Mater. Res. A 95, 801 (2010).
20. H. Mok and T. G. Park, Eur J. Pharm. Biopharm. 68, 105 (2008).
21. J. Dai, S. Zou, Y Pei, D. Cheng, H. Ai, and X. Shuai, Biomaterials 32, 1694 (2011).
22. T. Wang and N. He, Nanoscale 2, 230 (2010).
23. T. Wang, D. Li, X. Lu, A. Khmaladze, X. Han, S. Ye, P. Yang G. Xue, N. He, and Z. Chen, J. Phys. Chem. C. Nanomater Inter faces 115, 7613 (2011).
24. V. Cebrian, F. Martin-Saavedra, C. Yague, M. Arruebo, J. Santamaria, and N. Vilaboa, Acta Biomater. 7, 3645 (2011).
25. J. Z. Deng, Y X. Sun, H. Y Wang, C. Li, F W Huang, S. X. Cheng, R. X. Zhuo, and X. Z. Zhang, Acta Biomater. 7, 2200 (2011).
26. Y Wang, M. Zheng, F Meng, J. Zhang, R. Peng, and Z. Zhong, Biomacromolecules 12, 1032 (2011).
27. X. Gao, B. Kan, M. Gou, J. Zhang, G. Guo, N. Huang, X. Zhao, and Z. Qian, J. Biomed. Nanotechnol. 7, 285 (2011).
28. K. Ma, M. Hu, Y Qi, L. Qiu, Y Jin, J. Yu, and B. Li, Biomaterials 30, 3780 (2009)
29. K. Ma, M. Hu, M. Xie, H. Shen, L. Qiu, W Fan, H. Sun, S. Chen, and Y Jin, J. Gene Med. 12, 669 (2010).
30. R. Namgung, K. Singha, M. K. Yu, S. Jon, Y S. Kim, Y Ahn, I. K. Park, and W J. Kim, Biomaterials 31, 4204 (2010).
31. P. D. Williams and P. A. Kingston, Cardiovasc. Res. 91, 565 (2011).
32. M. Zhang, H. Yuan, Z. Huang, and F Hu, Zhong Nan Da Xue Xue Ba. Y. Xue Ban 36, 178 (2011).
33. M. L. Rogers and R. A. Rush, J. Control. Release (2011), Epub ahead of print.
34. A. K. Verma, R. P. Pandey, A. Chanchal, and P. Sharma, J. Biomed. Nanotechnol. 7, 63 (2011).
35. L. Chen, I. Borozan, J. Sun, M. Guindi, S. Fischer, J. Feld, N. Anand, J. Heathcote, A. M. Edwards, and I. D. McGilvray, Gastroenterology 138, 1123 (2010).
36. T. Wang, Z. Feng, N. He, Z. Wang, S. Li, Y Guo, and L. Xu, J. Nanosci. Nanotechnol. 7, 4571 (2007).
37. G.G. Gauglitz and M. G. Jeschke, Mol. Pharm. 8, 1471 (2011).
38. G. E. Poinern, D. Fawcett, Y J. Ng, N. Ali, R. K. Brundavanam, and Z. T. Jiang, J. Biomed. Nanotechnol. 6, 497 (2010).
39. K. Kolostova, O. Taltynov, D. Pinterova, M. Boubelik, O. Raska, P. Hozak, M. Jirkovska, and V. Bobek, Am. J. Otolaryngol. (2011).
40. X. Qi, Z. Chang, J. Song, G. Gao, and Z. Shen, Anticancer Drugs 22, 556 (2011).
41. N. S. Rejinold, M. Muthunarayanan, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, J. Biomed. Nanotechnol. 7, 521 (2011).
42. Y Wang, B. F Canine, and A. Hatefi, Nanomedicine 7, 193 (2011).
43. L. Tan, B. Xu, R. Liu, H. Liu, H. Tan, and W Huang, Cancer Biol. Ther. 9, 350 (2010).
44. Y Heike, Nihon. Rinsho. 67, 1958 (2009).
45. K. Allers, G. Hutter, J. Hofmann, C. Loddenkemper, K. Rieger, E. Thiel, and T. Schneider, Blood 117, 2791 (2011).
46. S. Nimesh, N. Gupta, and R. Chandra, J. Biomed. Nanotechnol. 7, 504 (2011).